AACCE Investments
ScreenerStocksIndicesPicksETFsBlogPricing

© 2026 ACCE Investments. All rights reserved.

ACCE Investments - Institutional-grade stock research for retail investors | BetaList
IndicesStocksETFsScreenerBlogGlossaryCompareMarket dataAdvisors
TermsPrivacyCookiesDisclaimerLegal noticeProfessional termsAboutContact
IVDA

Iveda Solutions Inc. Common Stock (IVDA) fair value

Industrials · Security & Protection Services · NASDAQ · United States
$0.23+0.04%
Market cap $3MNext earnings 2026-11-13Updated Oct 21, 2026
Add earnings to calendarGoogle
Our verdict
Trades 31% below our fair value
Price
$0.23
Model fair valueConfidence: low
about $0.33
Built from weaker models, sales multiples or analyst targets, so treat it as a rough guide.
Not used by alerts or posts.
Valued as a pre-revenue company: Net cash floor.
ACCE opinionIveda Solutions Inc. Common Stock (IVDA)
Fair value
Not available
ACCE price target
$0.19
Rating
Not rated
Horizon
12 months
ACCE price target published on 15 Oct 2026, 00:00 CEST.
Price used: $0.23 at the close on 23 Oct 2026, 22:00 CEST.
Models: Net cash floor.
Fair value: the average of the applicable valuation models (discounted cash flow, multiples, residual income, dividend discount, shareholder yield), each run on the latest financial statements and the market price shown. Opinion columns (fair value, target, rating) are shown apart from the data. Full methodology: acceinvestments.com/data/how-we-value-stocks
Full methodology
Conflicts of interest: The author holds no personal position in this security. General statement
Produced by ACCE Investments (acceinvestments.com)
Data
ACCE score
22
out of 100
Analysts
100% buy
1 covering
P/E
0.0x
forward 0.0x
1-year return
-81.6%
Dividend yield
0.00%

Iveda Solutions Inc. Common Stock in four questions

Plain answers, details below
Free accounts get 5 full stock pages a month, including the four answers.
OverviewAsk ACCEValuationQualityAnalystsSmart MoneyCompareNews and Record

Overview

ACCE thesis

Iveda Solutions sells AI-enabled video surveillance hardware, cloud video management software and related monitoring services to municipalities and enterprise customers, with a particular presence in Taiwan through its Iveda Taiwan subsidiary. The structural case rests on video analytics becoming a standard layer in physical security, which should support recurring software and service revenue over the hardware sale. The problem is that revenue fell 47.5% year on year and the operating margin of -88.6% shows the cost base has not followed the top line down. The near-term catalyst would be a new municipal or enterprise contract large enough to reverse the revenue decline, and nothing in the data here confirms one. With a 25/100 score, a 3M market cap and a -92.0% return on equity, this is a turnaround candidate that needs evidence of stabilising sales and a path to cost reduction before it merits deeper work.

AI-assisted·How I use AIWritten Oct 18, 2026
⚠ Investor warnings · 3 flagsAI-assisted·How I use AI
  • severe
    Going concern risk
    Market cap is $3M with FCF of -$2.03M and operating margin of -88.6%. Revenue fell 47.5% YoY. Cash runway is a live question, and dilution or insolvency is a real possibility.
  • high
    Revenue collapse
    Revenue declined 47.5% year over year despite a 28.9% five-year CAGR. The trend has reversed sharply, and the 342% QoQ bounce does not offset it.
  • high
    Deep operating losses
    Operating margin is -88.6% and net margin -69.2%, with ROE at -92.0%. The business is losing most of its revenue before overhead is covered.

AI research notes

AI-assisted·How I use AIWritten Oct 14, 2026 · figures from 2026-06-30 · prices to Oct 23, 2026
Why it could do well
  • Iveda's five-year average revenue growth of 28.9% per year shows the business has expanded considerably over time.
  • Debt is small relative to equity, with debt to equity at 0.09, so the balance sheet carries little borrowing.
Why it could disappoint
  • Revenue fell 47.5% over the past year, a sharp reversal from its longer-term growth trend.
  • Free cash flow over the last 12 months was negative at -$2M, so the business is consuming cash rather than generating it.
  • Diluted share count rose 38.2% last fiscal year, diluting existing shareholders' stakes in the company.
Each chip shows the exact figure and where it comes from. A claim without a source is not published.

Next results

Nov 13, 2026
We update the fair value about 2 days after the results, once the new figures are filed.Add to calendarGoogle

Walk me through this stock

Plain-English pros, cons, and what to watch. Pro feature.

PRO

Ask ACCE

Valuation

INVESTOR
Where IVDA's valuation models land
Price
$0.23
Model fair valueConfidence: low
about $0.33
Model
Fair value
Upside
Net cash floor
Create a free account: 5 full stock pages a month, no card.

See what each model says, the assumptions behind it, the bad, normal and good cases, and why the fair value changed.

Quality

INVESTOR
Quality and conviction INVESTOR FEATURE

The full quality picture: a reason under every score, how the scores moved, and the conviction breakdown.

  • +A plain reason under every score
  • +Conviction breakdown and growth / value / quality / momentum scores
  • +Score history: how each score moved over time

Analysts

Wall Street consensus

Bullish100% buy · 1 covering analyst
● Strong buy 0● Buy 1● Hold 0● Sell 0● Strong sell 0
Analyst intelligence INVESTOR FEATURE

The full analyst picture: the price-target distribution against the current price, forward consensus estimates, and how ACCE's own models compare.

  • +Price-target low / average / high vs the current price, with implied upside
  • +Forward revenue and EPS consensus by fiscal year
  • +ACCE fair-value models lined up against the Street

Smart Money

PRO

In one line

Trades are only made public after a delay. We show the delay so you know how old the news is.

Company insiders
No trades filed
Last 90 days
Congress
No trades filed
Last 180 days
Average delay
No trades filed
From trade to public filing
Do politicians beat the market? Our backtest →
Smart money tracking PRO FEATURE

Follow the informed money: 13F position changes, insider and Congress trades, and 13D activist filings.

  • +Quarter-over-quarter institutional position changes
  • +Every insider and Congress trade, with how late it was disclosed
  • +Active 13D activist filings and top holders

Compare

Where it sits vs peers

News and Record

Press releases mentioning this company

Recent performance

1 week
+0.0%
1 month
-25.8%
3 months
-4.2%
6 months
-23.3%
YTD
-72.6%
1 year
-81.6%

SEC filings

Recommendation history, last 12 months

DateTypeNewPreviousPrice
15 Oct 2026, 00:00 CESTACCE price target$0.19first publication$0.26

This analysis is not personalised investment advice and does not take your situation, objectives or risk tolerance into account. ACCE Investments is not an authorised investment firm.

Investing in shares carries a risk of losing capital. The value of an investment can go down as well as up.

Valuation horizon: 12 months from the publication date.

Conflicts of interest. ACCE Investments is operated by Adrien Chantreuil, who may hold personal positions in the securities analysed. Positions are declared on each security. ACCE receives no payment from the companies analysed or from any intermediary for this analysis.

Get the full IVDA page, free

Every model, the scenarios, fair value history, AI notes and the four questions. 5 full stock pages every month on the free plan, no card.

Free accounts get 5 full stock pages a month, including the full page.

Snapshot

Growth7Value23Quality39Momentum17Total22
Valuation
Trailing P/E
0.0x
Forward P/E
0.0x
PEG
no data
P/B
3.99x
EV / Revenue
0.1x
Book value/sh
$0.43
Enterprise value
$6M
Profitability
ROE
-92.0%
FCF yield
-70.08%
ROIC
-50.2%
Health and risk
Debt / equity
0.09
Dividend yield
0.00%
Beta
1.26

Price

-82.7% · 1Y

Ask anything about IVDA

Answered from Iveda Solutions Inc. Common Stock fundamentals + recent valuations. Every number shows its source and date.

This stock Peer Peer median weaker → stronger
P/Ebetter than 100% of peers
low 0.0x0.0xhigh 11.6x
ROEbetter than 17% of peers
low -108%-92%high 11%
Div yieldbetter than 83% of peers
low 0.0%0.0%high 6.7%

Peers

Prices Oct 23, 2026
CompanyPriceFair valuevs fair valueP/EROEQualityScore
IVDA Iveda Solutions Inc. Common Stock$0.23----92.0%3922
BKYI BIO-key International Inc. Common Stock$3.39----107.9%4736
GFAI Guardforce AI Co. Limited Ordinary Shares$0.19----19.6%3127
LEVEL.ST Nordic LEVEL Group AB (publ.)kr 0.30----14.2%3931
ALAQU.PA Aquila SA€3.70€522% below11.6x11.0%3946
PREC.ST Precise Biometrics AB (publ)kr 0.47----18.1%4723
IRIS.ST Irisity AB (publ)kr 0.22----50.2%3156

Sector report card

Where IVDA ranks against its sector peers on each metric.

Computing percentiles…
  • Business Wire•Oct 13, 2026
    Iveda and GlobalMed to Host Live IvedaAir Flight Demonstration for Government and Defense Stakeholders
  • Business Wire•Sep 9, 2026
    NASDAQ Grants Iveda Additional 180-Day Period to Regain Minimum Bid Price Compliance
  • Business Wire•Sep 2, 2026
    IvedaAir Draws Fortune 500 Defense and Government Interest Following Launch, Advances Toward Fall Flight Demonstration
7 more press releases · full archive on Investor+.INVESTOR
20 filings of 33
October 2026
Oct 16
ProxyProxy statementPeriod 2026-10-16
View on SEC →
September 2026
Sep 9
8-KCurrent reportPeriod 2026-09-04
View on SEC →
August 2026
Aug 14
10-QQuarterly reportPeriod 2026-06-30
View on SEC →
17 more filings + AI summaries on Investor+.INVESTOR